Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yun-Bi Ni

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Breast Cancer Research and Treatment|August 6, 2013
CX3CL1 expression is associated with poor outcome in breast cancer patientsJulia Y S Tsang, Yun-Bi Ni, Siu-Ki Chan, et al.
Breast Cancer Research and Treatment|April 12, 2021
SETD2 alterations and histone H3K36 trimethylation in phyllodes tumor of breastJulia Y Tsang, Sui-Ting Lai, Yun-Bi Ni, et al.
Journal of Clinical Pathology|August 13, 2018
CD147 expression is associated with poor overall survival in chemotherapy treated triple-negative breast cancerMing Liu, Julia Y S Tsang, Michelle Lee, et al.
Scientific Reports|March 3, 2018
Association of clinicopathological features and prognosis of TERT alterations in phyllodes tumor of breastJulia Y S Tsang, Yau-Kam Hui, Michelle A Lee, et al.
The Oncologist|August 16, 2018
Amyloid Precursor Protein Is Associated with Aggressive Behavior in Nonluminal Breast CancersJulia Y S Tsang, Michelle A Lee, Yun-Bi Ni, et al.
Cancer Research and Treatment|August 24, 2018
The Clinical Value of PELP1 for Breast Cancer: A Comparison with Multiple Cancers and Analysis in Breast Cancer SubtypesXingen Wang, Julia Y S Tsang, Michelle A Lee, et al.
Oncotarget|December 2, 2015
Doublecortin-like kinase 1 expression associates with breast cancer with neuroendocrine differentiationYu-Hong Liu, Julia Y S Tsang, Yun-Bi Ni, et al.
Histopathology|May 9, 2014
Immunohistochemistry in the diagnosis of papillary lesions of the breastGary M Tse, Yun-Bi Ni, Julia Y S Tsang, et al.
Cancer Immunology, Immunotherapy : CII|February 15, 2020
Co-expression of HLA-I loci improved prognostication in HER2+ breast cancersJulia Y Tsang, Chun-Sing Ho, Yun-Bi Ni, et al.
Breast Cancer Research and Treatment|January 7, 2017
PD-L1 expression and tumor infiltrating PD-1+ lymphocytes associated with outcome in HER2+ breast cancer patientsJulia Y S Tsang, Wai-Ling Au, Kwan-Yin Lo, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Breast Cancer Research and Treatment|August 6, 2013
CX3CL1 expression is associated with poor outcome in breast cancer patientsJulia Y S Tsang, Yun-Bi Ni, Siu-Ki Chan, et al.
Breast Cancer Research and Treatment|April 12, 2021
SETD2 alterations and histone H3K36 trimethylation in phyllodes tumor of breastJulia Y Tsang, Sui-Ting Lai, Yun-Bi Ni, et al.
Journal of Clinical Pathology|August 13, 2018
CD147 expression is associated with poor overall survival in chemotherapy treated triple-negative breast cancerMing Liu, Julia Y S Tsang, Michelle Lee, et al.
Scientific Reports|March 3, 2018
Association of clinicopathological features and prognosis of TERT alterations in phyllodes tumor of breastJulia Y S Tsang, Yau-Kam Hui, Michelle A Lee, et al.
The Oncologist|August 16, 2018
Amyloid Precursor Protein Is Associated with Aggressive Behavior in Nonluminal Breast CancersJulia Y S Tsang, Michelle A Lee, Yun-Bi Ni, et al.
Cancer Research and Treatment|August 24, 2018
The Clinical Value of PELP1 for Breast Cancer: A Comparison with Multiple Cancers and Analysis in Breast Cancer SubtypesXingen Wang, Julia Y S Tsang, Michelle A Lee, et al.
Oncotarget|December 2, 2015
Doublecortin-like kinase 1 expression associates with breast cancer with neuroendocrine differentiationYu-Hong Liu, Julia Y S Tsang, Yun-Bi Ni, et al.
Histopathology|May 9, 2014
Immunohistochemistry in the diagnosis of papillary lesions of the breastGary M Tse, Yun-Bi Ni, Julia Y S Tsang, et al.
Cancer Immunology, Immunotherapy : CII|February 15, 2020
Co-expression of HLA-I loci improved prognostication in HER2+ breast cancersJulia Y Tsang, Chun-Sing Ho, Yun-Bi Ni, et al.
Breast Cancer Research and Treatment|January 7, 2017
PD-L1 expression and tumor infiltrating PD-1+ lymphocytes associated with outcome in HER2+ breast cancer patientsJulia Y S Tsang, Wai-Ling Au, Kwan-Yin Lo, et al.
Pageof 5